The Hydration Pharmaceuticals Company Ltd
The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. The company sells its products under the Hydralyte brand through retail stores and online. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is based in Melbourne, Australi… Read more
The Hydration Pharmaceuticals Company Ltd (HPC) - Total Liabilities
Latest total liabilities as of June 2025: AU$1.22 Million AUD
Based on the latest financial reports, The Hydration Pharmaceuticals Company Ltd (HPC) has total liabilities worth AU$1.22 Million AUD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
The Hydration Pharmaceuticals Company Ltd - Total Liabilities Trend (2018–2024)
This chart illustrates how The Hydration Pharmaceuticals Company Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
The Hydration Pharmaceuticals Company Ltd Competitors by Total Liabilities
The table below lists competitors of The Hydration Pharmaceuticals Company Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ProConcept Marketing Group Inc.
PINK:LNTO
|
USA | $1.00 Million |
|
Spuntech
TA:SPNTC
|
Israel | ILA320.11 Million |
|
Kaixin Auto Holdings
NASDAQ:KXIN
|
USA | $9.67 Million |
|
Environmental Waste International Inc
PINK:YEWTF
|
USA | $6.40 Million |
|
BANCA GENERALI
BE:B7A
|
Germany | €13.53 Billion |
|
Viracta Therapeutics Inc
NASDAQ:VIRX
|
USA | $28.57 Million |
|
Xigem Technologies Corporation
PINK:XIGMF
|
USA | $877.20K |
Liability Composition Analysis (2018–2024)
This chart breaks down The Hydration Pharmaceuticals Company Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how The Hydration Pharmaceuticals Company Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for The Hydration Pharmaceuticals Company Ltd (2018–2024)
The table below shows the annual total liabilities of The Hydration Pharmaceuticals Company Ltd from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | AU$2.25 Million | -68.02% |
| 2023-12-31 | AU$7.05 Million | +9.99% |
| 2022-12-31 | AU$6.41 Million | +208.33% |
| 2021-12-31 | AU$2.08 Million | -14.91% |
| 2020-12-31 | AU$2.44 Million | +39.15% |
| 2019-12-31 | AU$1.76 Million | +11.26% |
| 2018-12-31 | AU$1.58 Million | -- |